Solubilization and Characterization of Muscarinic Acetylcholine Receptors View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1984

AUTHORS

E. C. Hulme , N. J. M. Birdsall , C. P. Berrie , T. Haga , J. M. Stockton

ABSTRACT

Three distinct types of detergent have been found to be capable of solubilizing muscarinic binding activity from the rat forebrain. These are: (a) the alkylpolyoxyethylenes such as Lubrol PX [1]; (b) steroids such as cholate [2, 3], digitonin [4, 5] and the cholate sulphobetaine derivative CHAPS [6]; and (c) lysophosphatidylcholine [7]. In such studies, it has proved convenient to compare the overall yield of solubilized receptors from brain membranes (P2 and P3) pre-labelled with the irreversible alkylating affinity label [3H]propylbenzilylcholine (3H-PrBCM) [8] with the yield of active binding sites which can be assayed in the supernatant after extraction of non-pre-labelled membranes. Solubilized binding sites were conveniently measured by incubating 600,000 g-min supernatants with receptor-saturating concentrations (3 × 10-8 M) of (-)-N-[Me-3H]- scopolamine (3H-NMS) or (-)-[3H]quinuclidinyl-benzilate (3H-QNB), followed by separation of bound from free ligand by rapid gel filtration on small columns of Sephadex G-50 M [3]. More... »

PAGES

421-423

Book

TITLE

Investigation of Membrane-Located Receptors

ISBN

978-1-4684-4633-3
978-1-4684-4631-9

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46

DOI

http://dx.doi.org/10.1007/978-1-4684-4631-9_46

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021187127


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hulme", 
        "givenName": "E. C.", 
        "id": "sg:person.01261741527.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261741527.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Birdsall", 
        "givenName": "N. J. M.", 
        "id": "sg:person.011475722264.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011475722264.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berrie", 
        "givenName": "C. P.", 
        "id": "sg:person.0764457447.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764457447.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haga", 
        "givenName": "T.", 
        "id": "sg:person.01032572647.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032572647.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stockton", 
        "givenName": "J. M.", 
        "id": "sg:person.01215134447.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215134447.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0003-9861(78)90296-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001676105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.77.11.6368", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002238097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-5793(78)81063-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003866577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.1979.tb13685.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028880890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(82)90694-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048475112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(82)90694-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048475112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-5793(80)80497-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048905138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.1974.tb09658.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052318019"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1984", 
    "datePublishedReg": "1984-01-01", 
    "description": "Three distinct types of detergent have been found to be capable of solubilizing muscarinic binding activity from the rat forebrain. These are: (a) the alkylpolyoxyethylenes such as Lubrol PX [1]; (b) steroids such as cholate [2, 3], digitonin [4, 5] and the cholate sulphobetaine derivative CHAPS [6]; and (c) lysophosphatidylcholine [7]. In such studies, it has proved convenient to compare the overall yield of solubilized receptors from brain membranes (P2 and P3) pre-labelled with the irreversible alkylating affinity label [3H]propylbenzilylcholine (3H-PrBCM) [8] with the yield of active binding sites which can be assayed in the supernatant after extraction of non-pre-labelled membranes. Solubilized binding sites were conveniently measured by incubating 600,000 g-min supernatants with receptor-saturating concentrations (3 \u00d7 10-8 M) of (-)-N-[Me-3H]- scopolamine (3H-NMS) or (-)-[3H]quinuclidinyl-benzilate (3H-QNB), followed by separation of bound from free ligand by rapid gel filtration on small columns of Sephadex G-50 M [3].", 
    "editor": [
      {
        "familyName": "Reid", 
        "givenName": "Eric", 
        "type": "Person"
      }, 
      {
        "familyName": "Cook", 
        "givenName": "G. M. W.", 
        "type": "Person"
      }, 
      {
        "familyName": "Morr\u00e9", 
        "givenName": "D. J.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4684-4631-9_46", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4684-4633-3", 
        "978-1-4684-4631-9"
      ], 
      "name": "Investigation of Membrane-Located Receptors", 
      "type": "Book"
    }, 
    "name": "Solubilization and Characterization of Muscarinic Acetylcholine Receptors", 
    "pagination": "421-423", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4684-4631-9_46"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "64f1f630075d4a3390a35b45afb0e193bcb2bd20aed9b5cce00fcd7630594a3e"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021187127"
        ]
      }
    ], 
    "publisher": {
      "location": "Boston, MA", 
      "name": "Springer US", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4684-4631-9_46", 
      "https://app.dimensions.ai/details/publication/pub.1021187127"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T00:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000256.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-1-4684-4631-9_46"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'


 

This table displays all metadata directly associated to this object as RDF triples.

124 TRIPLES      23 PREDICATES      34 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4684-4631-9_46 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Nf9cd323a50aa41748d1258d300cbcb39
4 schema:citation https://doi.org/10.1016/0003-9861(78)90296-5
5 https://doi.org/10.1016/0006-2952(82)90694-3
6 https://doi.org/10.1016/0014-5793(78)81063-1
7 https://doi.org/10.1016/0014-5793(80)80497-2
8 https://doi.org/10.1073/pnas.77.11.6368
9 https://doi.org/10.1111/j.1476-5381.1974.tb09658.x
10 https://doi.org/10.1111/j.1476-5381.1979.tb13685.x
11 schema:datePublished 1984
12 schema:datePublishedReg 1984-01-01
13 schema:description Three distinct types of detergent have been found to be capable of solubilizing muscarinic binding activity from the rat forebrain. These are: (a) the alkylpolyoxyethylenes such as Lubrol PX [1]; (b) steroids such as cholate [2, 3], digitonin [4, 5] and the cholate sulphobetaine derivative CHAPS [6]; and (c) lysophosphatidylcholine [7]. In such studies, it has proved convenient to compare the overall yield of solubilized receptors from brain membranes (P2 and P3) pre-labelled with the irreversible alkylating affinity label [3H]propylbenzilylcholine (3H-PrBCM) [8] with the yield of active binding sites which can be assayed in the supernatant after extraction of non-pre-labelled membranes. Solubilized binding sites were conveniently measured by incubating 600,000 g-min supernatants with receptor-saturating concentrations (3 × 10-8 M) of (-)-N-[Me-3H]- scopolamine (3H-NMS) or (-)-[3H]quinuclidinyl-benzilate (3H-QNB), followed by separation of bound from free ligand by rapid gel filtration on small columns of Sephadex G-50 M [3].
14 schema:editor N6a780b2312cc441f9cee168afd7314e4
15 schema:genre chapter
16 schema:inLanguage en
17 schema:isAccessibleForFree false
18 schema:isPartOf Na51d9d45a5134aacb1954b2df6e8d11f
19 schema:name Solubilization and Characterization of Muscarinic Acetylcholine Receptors
20 schema:pagination 421-423
21 schema:productId Naad5ebea30004953bc9bbbf7bb3a0a6d
22 Nc18e0ef5f61340679d625af281427e10
23 Ne650ae280c5642b5b8e5ab25fd423cf3
24 schema:publisher N479aed95800b4c8c961402dbf92ff784
25 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021187127
26 https://doi.org/10.1007/978-1-4684-4631-9_46
27 schema:sdDatePublished 2019-04-16T00:48
28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
29 schema:sdPublisher N2bd511b5cefa4bfa907f41c1e0af8aaa
30 schema:url http://link.springer.com/10.1007/978-1-4684-4631-9_46
31 sgo:license sg:explorer/license/
32 sgo:sdDataset chapters
33 rdf:type schema:Chapter
34 N2bd511b5cefa4bfa907f41c1e0af8aaa schema:name Springer Nature - SN SciGraph project
35 rdf:type schema:Organization
36 N3a45ed111d11484f8d3230eab5bd937e rdf:first sg:person.0764457447.89
37 rdf:rest Nca8fd051ec0748b99f4b575c330cabb8
38 N479aed95800b4c8c961402dbf92ff784 schema:location Boston, MA
39 schema:name Springer US
40 rdf:type schema:Organisation
41 N6a780b2312cc441f9cee168afd7314e4 rdf:first N7d0386761815446ca98be8c73c5c4a02
42 rdf:rest Nd61cc472bfb149d086d2eeef35ffd909
43 N6ab62fcb8f1b4121a47326b1deda0ed8 rdf:first N85bef59f0fca4f5eb5e01d3887cecaf5
44 rdf:rest rdf:nil
45 N7892cbbc962f44c6a95d49e286658c6a schema:familyName Cook
46 schema:givenName G. M. W.
47 rdf:type schema:Person
48 N7d0386761815446ca98be8c73c5c4a02 schema:familyName Reid
49 schema:givenName Eric
50 rdf:type schema:Person
51 N85bef59f0fca4f5eb5e01d3887cecaf5 schema:familyName Morré
52 schema:givenName D. J.
53 rdf:type schema:Person
54 Na51d9d45a5134aacb1954b2df6e8d11f schema:isbn 978-1-4684-4631-9
55 978-1-4684-4633-3
56 schema:name Investigation of Membrane-Located Receptors
57 rdf:type schema:Book
58 Naad5ebea30004953bc9bbbf7bb3a0a6d schema:name dimensions_id
59 schema:value pub.1021187127
60 rdf:type schema:PropertyValue
61 Nac89e9993d0040b5a21577bfc5aff89c rdf:first sg:person.011475722264.08
62 rdf:rest N3a45ed111d11484f8d3230eab5bd937e
63 Nb6cc267798134c1eae760a03554415a0 rdf:first sg:person.01215134447.17
64 rdf:rest rdf:nil
65 Nc18e0ef5f61340679d625af281427e10 schema:name doi
66 schema:value 10.1007/978-1-4684-4631-9_46
67 rdf:type schema:PropertyValue
68 Nca8fd051ec0748b99f4b575c330cabb8 rdf:first sg:person.01032572647.74
69 rdf:rest Nb6cc267798134c1eae760a03554415a0
70 Nd61cc472bfb149d086d2eeef35ffd909 rdf:first N7892cbbc962f44c6a95d49e286658c6a
71 rdf:rest N6ab62fcb8f1b4121a47326b1deda0ed8
72 Ne650ae280c5642b5b8e5ab25fd423cf3 schema:name readcube_id
73 schema:value 64f1f630075d4a3390a35b45afb0e193bcb2bd20aed9b5cce00fcd7630594a3e
74 rdf:type schema:PropertyValue
75 Nf9cd323a50aa41748d1258d300cbcb39 rdf:first sg:person.01261741527.53
76 rdf:rest Nac89e9993d0040b5a21577bfc5aff89c
77 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
78 schema:name Medical and Health Sciences
79 rdf:type schema:DefinedTerm
80 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
81 schema:name Pharmacology and Pharmaceutical Sciences
82 rdf:type schema:DefinedTerm
83 sg:person.01032572647.74 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
84 schema:familyName Haga
85 schema:givenName T.
86 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032572647.74
87 rdf:type schema:Person
88 sg:person.011475722264.08 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
89 schema:familyName Birdsall
90 schema:givenName N. J. M.
91 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011475722264.08
92 rdf:type schema:Person
93 sg:person.01215134447.17 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
94 schema:familyName Stockton
95 schema:givenName J. M.
96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215134447.17
97 rdf:type schema:Person
98 sg:person.01261741527.53 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
99 schema:familyName Hulme
100 schema:givenName E. C.
101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261741527.53
102 rdf:type schema:Person
103 sg:person.0764457447.89 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
104 schema:familyName Berrie
105 schema:givenName C. P.
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764457447.89
107 rdf:type schema:Person
108 https://doi.org/10.1016/0003-9861(78)90296-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001676105
109 rdf:type schema:CreativeWork
110 https://doi.org/10.1016/0006-2952(82)90694-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048475112
111 rdf:type schema:CreativeWork
112 https://doi.org/10.1016/0014-5793(78)81063-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003866577
113 rdf:type schema:CreativeWork
114 https://doi.org/10.1016/0014-5793(80)80497-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048905138
115 rdf:type schema:CreativeWork
116 https://doi.org/10.1073/pnas.77.11.6368 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002238097
117 rdf:type schema:CreativeWork
118 https://doi.org/10.1111/j.1476-5381.1974.tb09658.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052318019
119 rdf:type schema:CreativeWork
120 https://doi.org/10.1111/j.1476-5381.1979.tb13685.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028880890
121 rdf:type schema:CreativeWork
122 https://www.grid.ac/institutes/grid.451388.3 schema:alternateName The Francis Crick Institute
123 schema:name Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK
124 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...